Vivre avec une maladie chroniqueFEUGIER, Pierre; MOUTEL, Grégoire.Correspondances en onco-hématologie. 2008, Vol 3, Num 4, issn 1954-4820, 17 p., SUPSerial Issue

ADÉNORATHIE SUPERFICIELLE: Orientation diagnostique = Superficial adenopathyFEUGIER, Pierre; PERROT, Aurore.La Revue du praticien (Paris). 2011, Vol 61, Num 1, pp 127-135, issn 0035-2640, 9 p.Article

Les maladies chroniques : un défi pour la médecine ?LEPLEGE, Alain.Correspondances en onco-hématologie. 2008, Vol 3, Num 4, pp 18-19, issn 1954-4820, 2 p., SUPArticle

Le soin au plus près du mode de vie du patient : les réseaux ville-hôpital et l'HADMOUTEL, Grégoire.Correspondances en onco-hématologie. 2008, Vol 3, Num 4, pp 15-15, issn 1954-4820, 1 p., SUPArticle

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcomeCHETAILLE, Bruno; BERTUCCI, Francois; MOLINA, Thierry et al.Blood. 2009, Vol 113, Num 12, pp 2765-2775, issn 0006-4971, 11 p.Article

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELAFITOUSSI, Olivier; BELHADJ, Karim; HERBRECHT, Raoul et al.Haematologica (Roma). 2011, Vol 96, Num 8, pp 1136-1143, issn 0390-6078, 8 p.Article

Immuno-Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA StudyCOPIE-BERGMAN, Christiane; GAULARD, Philippe; EMILE, Jean-François et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5573-5579, issn 0732-183X, 7 p.Article

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients : results of the GELA-GOELAMS FL2000 studySALLES, Gilles; MOUNIER, Nicolas; AUDHUY, Bruno et al.Blood. 2008, Vol 112, Num 13, pp 4824-4831, issn 0006-4971, 8 p.Article

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trialLEPRETRE, Stephane; AURRAN, Therese; CORRONT, Bernadette et al.Blood. 2012, Vol 119, Num 22, pp 5104-5110, issn 0006-4971, 7 p.Article

High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemiaCAZIN, Bruno; DIVINE, Marine; GROSBOIS, Bernard et al.British journal of haematology. 2008, Vol 143, Num 1, pp 54-59, issn 0007-1048, 6 p.Article

Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma : A GELA StudySEBBAN, Catherine; BRICE, Pauline; COIFFIER, Bertrand et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3614-3620, issn 0732-183X, 7 p.Article

Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cellsFEUGIER, Pierre; BENSOUSSAN, Daniele; BORDIGONI, Pierre et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 7, pp 878-884, issn 0041-1132, 7 p.Article

Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemiaCORNET, Edouard; TOMOWIAK, Cécile; VALIDIRE-CHARPY, Patricia et al.British journal of haematology. 2014, Vol 166, Num 3, pp 390-400, issn 0007-1048, 11 p.Article

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA studyJARDIN, Fabrice; JAIS, Jean-Philippe; THIEBLEMONT, Catherine et al.Blood. 2010, Vol 116, Num 7, pp 1092-1104, issn 0006-4971, 13 p.Article

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)RIBRAG, Vincent; TILLY, Herve; OFFNER, Firtz et al.European journal of cancer (1990). 2013, Vol 49, Num 4, pp 904-910, issn 0959-8049, 7 p.Article

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN StudyMORSCHHAUSER, Franck Andre; CARTRON, Guillaume; WENGER, Michael et al.Journal of clinical oncology. 2013, Vol 31, Num 23, pp 2912-2919, issn 0732-183X, 8 p.Article

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma : the GELF-94 randomized study from the groupe d'etude des lymphomes de l'adulte (GELA). CommentaryVAN BESIEN, Koen; SEBBAN, Catherine; DOYEN, Chantal et al.Blood. 2006, Vol 108, Num 8, issn 0006-4971, 2496-2497,2540-2544 [7 p.]Article

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiationFEUGIER, Pierre; LABOUYRIE, Eric; DELWAIL, Vincent et al.Blood. 2004, Vol 104, Num 9, pp 2675-2681, issn 0006-4971, 7 p.Article

Primary lymphoma of the liver: Clinical-pathological features and relationship with HCV infection in French patientsBRONOWICKI, Jean-Pierre; BINEAU, Catherine; CAZALS-HATEM, Dominique et al.Hepatology (Baltimore, Md.). 2003, Vol 37, Num 4, pp 781-787, issn 0270-9139, 7 p.Article

Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host diseaseBORDIGONI, Pierre; DIMICOLI, Sophie; CLEMENT, Laurence et al.British journal of haematology. 2006, Vol 135, Num 3, pp 382-385, issn 0007-1048, 4 p.Article

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosisSARKOZY, Clementine; BASEGGIO, Lucile; TRAVERSE-GLEHEN, Alexandra et al.British journal of haematology. 2014, Vol 164, Num 5, pp 659-667, issn 0007-1048, 9 p.Article

Impact of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High―Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMSDUPUIS, Jehan; BERRIOLO-RIEDINGER, Alina; COLOMBAT, Philippe et al.Journal of clinical oncology. 2012, Vol 30, Num 35, pp 4317-4322, issn 0732-183X, 6 p.Article

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trialSALLES, Gilles; SEYMOUR, John Francis; CABALLERO, Dolores et al.Lancet (British edition). 2011, Vol 377, Num 9759, pp 42-51, issn 0140-6736, 10 p.Article

Efficacy and Safety of the Combination of Rituximab, Fludarabine, and Mitoxantrone for Rituximab-Naive, Recurrent/Refractory Follicular Non-Hodgkin Lymphoma With High Tumor Burden: A Multicenter Phase 2 Trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS)MORSCHHAUSER, Franck; MOUNIER, Nicolas; SEBBAN, Catherine et al.Cancer. 2010, Vol 116, Num 18, pp 4299-4308, issn 0008-543X, 10 p.Article

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemiaTOUMILHAC, Olivier; CAZIN, Bruno; VILLEMAGNE, Bruno et al.Blood. 2004, Vol 103, Num 1, pp 363-365, issn 0006-4971, 3 p.Article